The European Medicines Agency (EMA) has said it has seen “promising evidence” that mRNA Covid-19 vaccines would be able to “neutralize” the Indian variant of the virus, and it is monitoring the situation closely.
The B.1.617.2 variant, which was first detected in India in October, has contributed towards the country’s devastating second wave of Covid-19 infections throughout April and into May.
Some hospitals have been pushed to breaking point by the admission of Covid-19 patients and have run out of supplies of oxygen to treat those with breathing…
